Biora Therapeutics is a biotechnology and health care startup that was founded in 2010. The company received a significant $50.00M Post-IPO Equity investment on 19 September 2023. This infusion of capital signifies a strong show of confidence in the company's potential for growth and innovation. As the industry continues to evolve, the investment in Biora Therapeutics reflects a keen interest in the development of groundbreaking solutions in biotechnology and health care. While the specific investors of this latest round of funding have not been disclosed, the amount itself underscores the promising prospects of Biora Therapeutics within the startup landscape. This infusion of funds positions the company strongly for further advancement and expansion within the industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Equity | $6.00M | - | 01 Apr 2024 | |
Post-IPO Equity | $50.00M | - | 19 Sep 2023 | |
Post-IPO Equity | $9.75M | - | 07 Nov 2022 | |
Post-IPO Equity | $20.00M | - | 04 Oct 2021 | |
Post-IPO Equity | $40.00M | - | 10 Jun 2021 |
No recent news or press coverage available for Biora Therapeutics.